Untargeted LC-HRMS Based-Plasma Metabolomics Reveals 3-O-Methyldopa as a New Biomarker of Poor Prognosis in High-Risk Neuroblastoma

Neuroblastoma (NB) is the most common extracranial malignant tumor in children. Although the survival rate of NB has improved over the years, the outcome of NB still remains poor for over 30% of cases. A more accurate risk stratification remains a key point in the study of NB and the availability of...

Descripción completa

Detalles Bibliográficos
Autores principales: Barco, Sebastiano, Lavarello, Chiara, Cangelosi, Davide, Morini, Martina, Eva, Alessandra, Oneto, Luca, Uva, Paolo, Tripodi, Gino, Garaventa, Alberto, Conte, Massimo, Petretto, Andrea, Cangemi, Giuliana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231354/
https://www.ncbi.nlm.nih.gov/pubmed/35756625
http://dx.doi.org/10.3389/fonc.2022.845936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231354/
https://www.ncbi.nlm.nih.gov/pubmed/35756625
http://dx.doi.org/10.3389/fonc.2022.845936

Ejemplares similares